Clinical Trial Update: Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy [NA]

View source ↗

Summary

A completed clinical trial evaluating hilotherapy to prevent oxaliplatin-induced peripheral neuropathy and its impact on quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Hilotherapy

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Quality of Life, Chemotherapy-induced Peripheral Neuropathy | NA | Status: COMPLETED